Search Results

There are 8337479 results for: content related to: Health-related quality of life and sorafenib

  1. You have free access to this content
    Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib

    Hepatology

    Volume 56, Issue 6, December 2012, Pages: 2363–2374, Carlo Spirli, Carola M. Morell, Luigi Locatelli, Stefano Okolicsanyi, Cecilia Ferrero, Amy K. Kim, Luca Fabris, Romina Fiorotto and Mario Strazzabosco

    Version of Record online : 27 AUG 2012, DOI: 10.1002/hep.25872

  2. Sorafenib sensitizes hepatocellular carcinoma cells to physiological apoptotic stimuli

    Journal of Cellular Physiology

    Volume 227, Issue 4, April 2012, Pages: 1319–1325, Joan Fernando, Patricia Sancho, Conrado M. Fernández-Rodriguez, José L. Lledó, Laia Caja, Jean S. Campbell, Nelson Fausto and Isabel Fabregat

    Version of Record online : 11 JAN 2012, DOI: 10.1002/jcp.22843

  3. You have free access to this content
    Complementary vascular and matrix regulatory pathways underlie the beneficial mechanism of action of sorafenib in liver fibrosis

    Hepatology

    Volume 54, Issue 2, August 2011, Pages: 573–585, Dominique Thabut, Chittaranjan Routray, Gwen Lomberk, Uday Shergill, Kevin Glaser, Robert Huebert, Leena Patel, Tetyana Masyuk, Boris Blechacz, Andrew Vercnocke, Erik Ritman, Richard Ehman, Raul Urrutia and Vijay Shah

    Version of Record online : 26 JUN 2011, DOI: 10.1002/hep.24427

  4. You have full text access to this OnlineOpen article
    Sorafenib synergizes with metformin in NSCLC through AMPK pathway activation

    International Journal of Cancer

    Volume 136, Issue 6, 15 March 2015, Pages: 1434–1444, Floris H. Groenendijk, Wouter W. Mellema, Eline van der Burg, Eva Schut, Michael Hauptmann, Hugo M. Horlings, Stefan M. Willems, Michel M. van den Heuvel, Jos Jonkers, Egbert F. Smit and René Bernards

    Version of Record online : 8 AUG 2014, DOI: 10.1002/ijc.29113

  5. Clinical features associated with radiological response to sorafenib in unresectable hepatocellular carcinoma: a large multicenter study in Japan

    Liver International

    Volume 35, Issue 5, May 2015, Pages: 1581–1589, Haruhiko Takeda, Hiroki Nishikawa, Yukio Osaki, Kaoru Tsuchiya, Kouji Joko, Chikara Ogawa, Hiroyoshi Taniguchi, Etsuro Orito, Yasushi Uchida, Namiki Izumi and Japanese Red Cross Liver Study Group

    Version of Record online : 9 JUN 2014, DOI: 10.1111/liv.12591

  6. You have free access to this content
    Sorafenib inhibits signal transducer and activator of transcription-3 signaling in cholangiocarcinoma cells by activating the phosphatase shatterproof 2

    Hepatology

    Volume 50, Issue 6, December 2009, Pages: 1861–1870, Boris R. A. Blechacz, Rory L. Smoot, Steven F. Bronk, Nathan W. Werneburg, Alphonse E. Sirica and Gregory J. Gores

    Version of Record online : 5 AUG 2009, DOI: 10.1002/hep.23214

  7. You have free access to this content
    Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease

    Arthritis & Rheumatism

    Volume 64, Issue 6, June 2012, Pages: 1990–2000, Niloufar Kavian, Amélie Servettaz, Wioleta Marut, Carole Nicco, Christiane Chéreau, Bernard Weill and Frédéric Batteux

    Version of Record online : 25 MAY 2012, DOI: 10.1002/art.34354

  8. You have free access to this content
    Inhibition of doxorubicin-induced autophagy in hepatocellular carcinoma Hep3B cells by sorafenib – the role of extracellular signal-regulated kinase counteraction

    The FEBS Journal

    Volume 278, Issue 18, September 2011, Pages: 3494–3507, Irena Manov, Yulia Pollak, Rinata Broneshter and Theodore C. Iancu

    Version of Record online : 5 SEP 2011, DOI: 10.1111/j.1742-4658.2011.08271.x

  9. You have free access to this content
    Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma

    International Journal of Cancer

    Volume 131, Issue 3, 1 August 2012, Pages: 548–557, Satoshi Shimizu, Tetsuo Takehara, Hayato Hikita, Takahiro Kodama, Hinako Tsunematsu, Takuya Miyagi, Atsushi Hosui, Hisashi Ishida, Tomohide Tatsumi, Tatsuya Kanto, Naoki Hiramatsu, Naonobu Fujita, Tamotsu Yoshimori and Norio Hayashi

    Version of Record online : 12 SEP 2011, DOI: 10.1002/ijc.26374

  10. Sorafenib induces endometrial carcinoma apoptosis by inhibiting Elk-1-dependent Mcl-1 transcription and inducing Akt/GSK3β-dependent protein degradation

    Journal of Cellular Biochemistry

    Volume 114, Issue 8, August 2013, Pages: 1819–1831, Nian-Kang Sun, Shang-Lang Huang, Ting-Chang Chang and Chuck C.-K. Chao

    Version of Record online : 11 JUN 2013, DOI: 10.1002/jcb.24530

  11. You have free access to this content
    Nuclear factor kappa B–mediated CD47 up-regulation promotes sorafenib resistance and its blockade synergizes the effect of sorafenib in hepatocellular carcinoma in mice

    Hepatology

    Volume 62, Issue 2, August 2015, Pages: 534–545, Jessica Lo, Eunice Yuen Ting Lau, Rachel Hiu Ha Ching, Bowie Yik Ling Cheng, Mark Kin Fai Ma, Irene Oi Lin Ng and Terence Kin Wah Lee

    Version of Record online : 3 JUN 2015, DOI: 10.1002/hep.27859

  12. Sorafenib combined vitamin K induces apoptosis in human pancreatic cancer cell lines through RAF/MEK/ERK and c-Jun NH2-terminal kinase pathways

    Journal of Cellular Physiology

    Volume 224, Issue 1, July 2010, Pages: 112–119, Gang Wei, Meifang Wang and Brian I. Carr

    Version of Record online : 18 MAR 2010, DOI: 10.1002/jcp.22099

  13. You have full text access to this OnlineOpen article
    Sorafenib treatment in children with relapsed and refractory neuroblastoma: an experience of four cases

    Cancer Medicine

    Volume 5, Issue 8, August 2016, Pages: 1947–1949, Keiko Okada, Yoshiko Nakano, Kai Yamasaki, Chika Nitani, Hiroyuki Fujisaki and Junichi Hara

    Version of Record online : 5 JUN 2016, DOI: 10.1002/cam4.784

  14. You have free access to this content
    Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinoma

    Hepatology

    Volume 57, Issue 3, March 2013, Pages: 1046–1054, Calogero Cammà, Giuseppe Cabibbo, Salvatore Petta, Marco Enea, Massimo Iavarone, Antonio Grieco, Antonio Gasbarrini, Erica Villa, Claudio Zavaglia, Raffaele Bruno, Massimo Colombo, Antonio Craxì and on behalf of the WEF and the SOFIA study groups

    Version of Record online : 12 FEB 2013, DOI: 10.1002/hep.26221

  15. Inhibition of myeloid cell leukemia-1: Association with sorafenib-induced apoptosis in human mucoepidermoid carcinoma cells and tumor xenograft

    Head & Neck

    Volume 37, Issue 9, September 2015, Pages: 1326–1335, Hyun-Ju Yu, Ji-Ae Shin, Ji-Youn Jung, Jeong-Seok Nam, In-Sun Hong, Nam-Pyo Cho and Sung-Dae Cho

    Version of Record online : 19 JUL 2014, DOI: 10.1002/hed.23749

  16. You have free access to this content
    EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib

    International Journal of Cancer

    Volume 131, Issue 12, 15 December 2012, Pages: 2961–2969, Zakaria Ezzoukhry, Christophe Louandre, Eric Trécherel, Corinne Godin, Bruno Chauffert, Sébastien Dupont, Momar Diouf, Jean-Claude Barbare, Jean-Claude Mazière and Antoine Galmiche

    Version of Record online : 30 APR 2012, DOI: 10.1002/ijc.27604

  17. Involvement of receptor tyrosine phosphatase DEP-1 mediated PI3K-cofilin signaling pathway in Sorafenib-induced cytoskeletal rearrangement in hepatoma cells

    Journal of Cellular Physiology

    Volume 224, Issue 2, August 2010, Pages: 559–565, Ziqiu Wang, Meifang Wang and Brian I. Carr

    Version of Record online : 21 APR 2010, DOI: 10.1002/jcp.22160

  18. You have free access to this content
    Sorafenib enriches epithelial cell adhesion molecule–positive tumor initiating cells and exacerbates a subtype of hepatocellular carcinoma through TSC2-AKT cascade

    Hepatology

    Volume 62, Issue 6, December 2015, Pages: 1791–1803, Dong-Xian Guan, Jie Shi, Yang Zhang, Jiang-Sha Zhao, Ling-Yun Long, Tian-Wei Chen, Er-Bin Zhang, Yuan-Yuan Feng, Wen-Dai Bao, Yue-Zhen Deng, Lin Qiu, Xue-Li Zhang, H. Phillip Koeffler, Shu-qun Cheng, Jing-Jing Li and Dong Xie

    Version of Record online : 24 OCT 2015, DOI: 10.1002/hep.28117

  19. You have free access to this content
    Concurrent radiotherapy and temozolomide followed by temozolomide and sorafenib in the first-line treatment of patients with glioblastoma multiforme

    Cancer

    Volume 116, Issue 15, 1 August 2010, Pages: 3663–3669, John D. Hainsworth, Thomas Ervin, Elke Friedman, Victor Priego, Patrick B. Murphy, Bobby L. Clark and Ruth E. Lamar

    Version of Record online : 11 MAY 2010, DOI: 10.1002/cncr.25275

  20. Sorafenib in a hepatocellular carcinoma patient with end-stage renal failure: A pharmacokinetic study

    Hepatology Research

    Volume 44, Issue 6, June 2014, Pages: 685–688, Takamichi Ishii, Etsuro Hatano, Kojiro Taura, Tomoyuki Mizuno, Tomoki Kawai, Masahide Fukudo, Toshiya Katsura and Shinji Uemoto

    Version of Record online : 30 MAY 2013, DOI: 10.1111/hepr.12156